ROBERT SCHREIBER and PHILIP GREENBERG were named editors-in-chief of Cancer Immunology Research, one of eight peer-reviewed journals published by the American Association for Cancer Research.
Cancer Immunology Research publishes original articles reporting advances in cancer immunology and immunotherapies that span the spectrum of science and medicine, from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials.
“In 2013, the AACR launched Cancer Immunology Research with Glenn Dranoff as the founding editor-in-chief to capture the most significant work in the field of cancer immunology and to highlight the relationship of cancer immunology to other areas of cancer research,” said Margaret Foti, chief executive officer of the AACR.
“The AACR owes much gratitude to Dr. Dranoff for his editorial vision and for the journal’s many early successes. Under the new leadership of Drs. Schreiber and Greenberg, the journal will continue its commitment to publish all aspects of cancer immunology and immunotherapy.”
Schreiber is the alumni endowed professor of pathology and immunology and director of the Center for Human Immunology and Immunotherapy Programs at Washington University School of Medicine in St. Louis.
Greenberg is a professor of medicine/oncology and immunology at the University of Washington and head of the Program in Immunology at the Fred Hutchinson Cancer Research Center in Seattle.
